All In Biotech

Drug Trial Radar · NCT06708416

A Study of ONO-1110 in Patients With Postherpetic Neuralgia

A Phase IIa, Randomized, Double-blind, Placebo Controlled, Parallel Group, Multi-center Trial to Evaluate the Efficacy and Safety of ONO-1110 in Patients With Postherpetic Neuralgia

Last checked: Nov 19, 2026Latest source record: Jul 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 142 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

142

Actual

Start

Feb 12, 2025

Primary completion

May 11, 2026

Study completion May 11, 2026

Sponsor

Lead sponsor
Ono Pharmaceutical Co., Ltd.Industry
Sponsor type
Industry
First posted
Nov 27, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the efficacy and safety of ONO-1110 in Japanese patients with postherpetic neuralgia

Conditions

  • Postherpetic Neuralgia

Interventions

  • ONO-1110Drug

    ONO-1110 tablets once a day

  • PlaceboDrug

    Placebo tablets once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in weekly mean of average pain score (last 7-day mean of past 24-hour average pain scores [NRS] in the pain diary) from baseline to Week 8 of the treatment periodTime frame: Up to 15 weeks
  2. Adverse EventsTime frame: Up to 15 weeks

Locations

31 sites in 1 country. Site status is shown where the registry gives one.

  • Kamezawa Clinic

    Aichi, Japan

  • Kimura Clinic

    Aichi, Japan

  • Fukuoka Tokushukai Hospital

    Fukuoka, Japan

  • Southern Tohoku General Hospital

    Fukushima, Japan

  • Central Japan International Medical Center

    Gifu, Japan

  • National Hospital Organization Kure Medical Center

    Hiroshima, Japan

  • National Hospital Organization Hokkaido Medical Center

    Hokkaido, Japan

  • Nishinomiya Municipal Central Hospital

    Hyōgo, Japan

  • Mito Saiseikai General Hospital

    Ibaraki, Japan

  • Kawasaki Municipal Hospital

    Kanagawa, Japan

  • Konan Hidamari Pain Clinic

    Kanagawa, Japan

  • Nomura Dermatology Clinic

    Kanagawa, Japan

  • Tai Clinic

    Kanagawa, Japan

  • Yokohama City Minato Red Cross Hospital

    Kanagawa, Japan

  • Junwakai Memorial Hospital

    Miyazaki, Japan

  • Medical Corporation Toyama Dermatology

    Miyazaki, Japan

  • Medical Corporation Fujigaki Clinic

    Ōita, Japan

  • Yuaikai Tomishiro Chuo Hospital

    Okinawa, Japan

  • Morimoto Clinic

    Osaka, Japan

  • Osaka Medical and Pharmaceutical University Hospital

    Osaka, Japan

  • Osaka Metropolitan University Hospital

    Osaka, Japan

  • Chutoen General Medical Center

    Shizuoka, Japan

  • Shizuoka Rehabili Pain Clinic

    Shizuoka, Japan

  • Fukuuchi Pain Clinic

    Tokyo, Japan

  • Fukuwa Clinic

    Tokyo, Japan

  • Futaki Skin Care Clinic

    Tokyo, Japan

  • Juntendo University Hospital

    Tokyo, Japan

  • Mitaka Pain Clinic

    Tokyo, Japan

  • Nishiogi Pain Clinic

    Tokyo, Japan

  • Tokyo-Eki Center-Building Clinic

    Tokyo, Japan

  • Yamanashi Prefectural Central Hospital

    Yamanashi, Japan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.